Department of Pediatrics, School of Medicine, Fujita Health University, Toyoake, Japan.
Ann Allergy Asthma Immunol. 2013 May;110(5):380-385.e1. doi: 10.1016/j.anai.2013.02.015. Epub 2013 Mar 15.
The involvement of a shift from TH2 to TH1 responses in peripheral blood in pollen subcutaneous immunotherapy (SCIT) has been contentious, partly because of difficulties analyzing antigen-specific TH cells.
To use recent technical advances to establish a more direct and simple method to analyze antigen-specific TH cells and to clarify the involvement of a TH2/TH1 shift in peripheral blood in pollen specific immunotherapy.
After short-term (6-hour) antigen stimulation, antigen-specific TH cells in peripheral blood of Japanese children and young adults with Japanese cedar pollinosis undergoing SCIT were analyzed by multicolor flow cytometry for the presence of the activation marker CD154 and intracellular cytokines.
Twenty-eight patients between 5 and 22 years of age were enrolled in the study; 22 had started SCIT after enrolling in the study (SCIT group), and the remaining 6 were planning to start SCIT in the next off-season (control group). The number of Japanese cedar-specific interleukin (IL) 5-, IL-4-, interferon γ-, IL-17A-, IL-10-, and tumor necrosis factor α-producing TH cells without antigen-driven cell proliferation was determined. The seasonal increase in the number of Japanese cedar-specific IL-5- and IL-4-producing TH cells seen in the control group was suppressed in the SCIT group (P < .005 and <.001, respectively).
We report a powerful method for the analysis of antigen-specific TH cells in peripheral blood. This method will contribute to our understanding of immune mechanisms of immunotherapy and help us develop more sophisticated allergen specific immunotherapy.
在花粉皮下免疫治疗(SCIT)中,外周血中从 TH2 向 TH1 反应的转变已经引起了争议,部分原因是分析抗原特异性 TH 细胞存在困难。
利用最近的技术进展,建立一种更直接和简单的方法来分析抗原特异性 TH 细胞,并阐明外周血中 TH2/TH1 转变在花粉特异性免疫治疗中的参与。
对接受 SCIT 的日本 cedar 花粉过敏的日本儿童和年轻成人外周血中的抗原特异性 TH 细胞进行短期(6 小时)抗原刺激后,通过多色流式细胞术分析激活标志物 CD154 和细胞内细胞因子的存在。
共纳入 28 名 5 至 22 岁的患者;其中 22 名在入组后开始 SCIT(SCIT 组),其余 6 名计划在下一个淡季开始 SCIT(对照组)。未发生抗原驱动的细胞增殖的情况下,测定日本 cedar 特异性白细胞介素(IL)5、IL-4、干扰素 γ、IL-17A、IL-10 和肿瘤坏死因子 α 产生 TH 细胞的数量。对照组中季节性增加的日本 cedar 特异性 IL-5 和 IL-4 产生 TH 细胞数量在 SCIT 组中受到抑制(分别为 P <.005 和 <.001)。
我们报告了一种分析外周血中抗原特异性 TH 细胞的有效方法。这种方法将有助于我们理解免疫治疗的免疫机制,并帮助我们开发更复杂的过敏原特异性免疫治疗。